Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Coldstream Laboratories has announced the expansion of key systems in its sterile drug product manufacturing plant to improve efficiencies and capacity for the production of parenteral products.
Subscribe to our email newsletter
Coldstream is also improving lyophilization capacity to expand the range of solvents that can safely be handled. The company expects to complete the upgrades in August 2012.
Coldstream operations vice president Vickie Hall said, "We are expanding our capacity to generate sterile water for injection and other systems to keep pace with demand."
The process began in 2011 with the expansion of the R&D lyophilization capabilities through facilities modification and the purchase of additional capacity, which also included a focus on increasing the solvents that can be used for product development, according to the company.
Coldstream executive vice president Eric Smart said, "While our lyophilization equipment was already capable of handling many organic solvents, these additional features will expand the number of solvents we can handle safely to help our clients overcome challenges in product development."